Your browser doesn't support javascript.
loading
Cladribine Treatment for MS Preserves the Differentiative Capacity of Subsequently Generated Monocytes, Whereas Its Administration In Vitro Acutely Influences Monocyte Differentiation but Not Microglial Activation.
Medeiros-Furquim, Tiago; Ayoub, Sinan; Johnson, Laura J; Aprico, Andrea; Nwoke, Eze; Binder, Michele D; Kilpatrick, Trevor J.
Affiliation
  • Medeiros-Furquim T; Department of Biomedical Sciences of Cells and Systems, Section Molecular Neurobiology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
  • Ayoub S; The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia.
  • Johnson LJ; The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia.
  • Aprico A; The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia.
  • Nwoke E; The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia.
  • Binder MD; The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia.
  • Kilpatrick TJ; The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia.
Front Immunol ; 13: 678817, 2022.
Article in En | MEDLINE | ID: mdl-35734180
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Monocytes / Multiple Sclerosis Limits: Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Monocytes / Multiple Sclerosis Limits: Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: Netherlands